PAR-01-101/102: Other options for submission

The National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) invite applications to develop novel in vivo image acquisition or enhancement methods, and incorporate limited pilot or feasibility evaluations using either pre-clinical models or clinical studies. This initiative is intended to facilitate the development of novel imaging technologies for early detection, screening, diagnosis, and image guided treatment of cancer and other diseases. The intent is to stimulate (a) the development of innovative image acquisition and enhancement methods, including high risk/high gain research on technologies that exploit our knowledge of the molecular basis of cancer or other disease, and (b) the integration of these emerging technologies with traditional imaging methods for more effective solutions for health care delivery. A phased innovation award mechanism (R21/R33) is proposed that is suitable for supporting imaging technology development. Applications from academia, industry, and independent research organizations are encouraged. Modifications to this reissued Program Announcement include support for a limited number of system prototypes for pilot or feasibility evaluations using either pre-clinical models or clinical studies. Applicants considering developments for ex vivo or in vitro molecular imaging are encouraged to read announcements PAR-01-105 and PAR-01-107 for Innovative Technologies for the Molecular Analysis of Cancer, listed under NCI Initiatives. Small business applicants with in vivo imaging interests are encouraged to apply under announcement, PAR-01-102.

• Release Date: May 29, 2001
• Letter of Intent Receipt Date(s): June 11, 2001, February 11, 2002 and June 11, 2002
• Application Receipt Date(s): July 16, 2001 and March 18, 2002, and July 16, 2002
• No set aside
• Contact: Houston Baker, Ph.D. at (hb4s@nih.gov) or Laurence Clarke, Ph.D. at (lclarke@mail.nih.gov).

See full description in NIH Guide: PAR-01-101